Cord tissue refers to the stem cells contained within the actual umbilical cord. Scientists have found that your baby’s umbilical cord is an exceptional source of valuable stem cells.
Cord tissue stem cells are vastly different from cord blood stem cells, but equally important.
Cord tissue stem cells, also known as Mesenchymal Stem Cells or MSCs, are found in the Wharton’s Jelly and perivascular regions of the umbilical cord.
MSCs are showing great potential in the fields of regenerative medicine, tissue engineering and gene therapy. They can differentiate into a variety of cell types, including bone, cartilage, muscle, nerve and others.
Mesenchymal stem cells from cord tissue represent the most advanced, cutting-edge discoveries in regenerative medicine today.
With over 300 MSC clinical trials and numerous research studies in process, scientists predict an explosion of new therapies will be universally adopted, including standard, routine treatments for autism, type 1 diabetes, spinal cord injury, traumatic brain injury, rheumatoid arthritis, multiple sclerosis, stroke, heart failure, liver damage and many more.
Also, the ability of cord tissue stem cells to suppress the body’s immune response has prompted doctors to use them in unison with cord blood stem cells to potentially reduce the effects of transplant rejection (GVHD). By using cord tissue stem cells along with cord blood stem cells, researchers have reported quicker cell engraftment and better transplant outcomes.
The use of cord tissue stem cells has the enormous potential to make regenerative medicine a life-saving reality. This is something that conventional medicine and pharmaceutical therapy have not been able to do effectively.
Private banking of both cord blood and cord tissue will provide your family with the most complete scope of future treatment options.
Scientists predict there will be an explosion of new therapies using cord tissue stem cells, as they represent the most advanced, cutting-edge discoveries in regenerative medicine today.